Patient Information: Summary of Product Characteristics
Abiraterona Farmoz 250 mg tablets EFG
abiraterone acetate
Read this entire leaflet carefully before you start taking this medicine, as it contains important information for you.
Contents of the pack
This medicine contains abiraterone acetate. It is used for the treatment of prostate cancer in adult men that has spread to other parts of the body. Abiraterone works by stopping your body from making testosterone, which helps to slow down the growth of prostate cancer.
When abiraterone is prescribed in the early stages of the disease and there is still a response to hormonal treatment, it is used together with a treatment to reduce testosterone levels (androgen deprivation therapy).
When you take this medicine, your doctor will also prescribe another medicine called prednisone or prednisolone to reduce the risk of high blood pressure, fluid retention, or low potassium levels in your blood.
Do not take Abiraterona Farmoz
Do not take this medicine if any of the above applies to you. If you are unsure, consult your doctor or pharmacist before taking this medicine.
Warnings and precautions
Talk to your doctor or pharmacist before starting this medicine:
Tell your doctor if you have been told you have any heart or blood vessel disorders, including heart rhythm problems (arrhythmia), or if you are being treated with medicines for these disorders.
Tell your doctor if you have yellowing of the skin or eyes, dark urine, or severe nausea or vomiting, as these can be signs or symptoms of liver problems. Rarely, acute liver failure (called acute hepatic insufficiency) can occur, which can be life-threatening.
A decrease in the number of red blood cells, reduced sexual desire, and cases of muscle weakness and/or muscle pain may occur.
Abiraterone should not be given in combination with Ra-223 due to a possible increased risk of bone fractures or death.
If you plan to take Ra-223 after treatment with this medicine and prednisone/prednisolone, you should wait 5 days before starting Ra-223 treatment.
If you are unsure if any of the above applies to you, consult your doctor or pharmacist before taking this medicine.
Blood tests
This medicine may affect your liver, even if you have no symptoms. While you are taking this medicine, your doctor will perform regular blood tests to check for any effects on your liver.
Children and adolescents
This medicine should not be used in children or adolescents. If a child or adolescent accidentally ingests this medicine, they should go to the hospital immediately and bring this leaflet to show the emergency doctor.
Other medicines and Abiraterona Farmoz
Consult your doctor or pharmacist before taking any other medicine.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. This is important because abiraterone can increase the effects of certain medicines, including heart medicines, sedatives, some diabetes medicines, herbal medicines (e.g., St. John's Wort), and others. Your doctor may consider changing the dose of these medicines. Additionally, some medicines can increase or decrease the effects of abiraterone, which can lead to side effects or reduced effectiveness of this medicine.
Androgen deprivation therapy may increase the risk of heart rhythm problems. Tell your doctor if you are being treated with medicines for heart rhythm problems (e.g., quinidine, procainamide, amiodarone, and sotalol) or medicines that increase the risk of heart rhythm problems [e.g., methadone (used for pain relief and as part of drug addiction detoxification), moxifloxacin (an antibiotic), antipsychotics (used for severe mental illnesses)].
Consult your doctor if you are taking any of the above medicines.
Abiraterona Farmoz with food
Pregnancy and breastfeeding
Abiraterona is not indicated in women.
Pregnant women or women who think they may be pregnant should wear gloves if they need to touch or handle this medicine.
This medicine may harm the fetus if taken by a pregnant woman.
If you have sex with a woman of childbearing age, you should use a condom and another effective contraceptive method.
If you have sex with a pregnant woman, you should use a condom to protect the fetus.
Driving and using machines
It is unlikely that this medicine will affect your ability to drive or use tools or machines.
Abiraterona Farmoz contains lactose and sodium
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
This medicine contains less than 41 mg of sodium (1 mmol) per dose of four tablets. This is equivalent to 2% of the maximum recommended daily intake of sodium for an adult.
Follow the instructions for administration of this medicine exactly as indicated by your doctor. If you are unsure, consult your doctor or pharmacist again.
How much to take
The recommended dose is 1,000 mg (four 250 mg tablets) once a day.
How to take this medicine
Your doctor may also prescribe other medicines while you are taking abiraterone and prednisone or prednisolone.
If you take more Abiraterona Farmoz than you should
If you take more than you should, talk to your doctor or go to the hospital immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Abiraterona Farmoz
If you stop taking Abiraterona Farmoz
Do not stop taking this medicine or prednisone or prednisolone unless your doctor tells you to. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking abiraterone and see your doctor immediately if you get any of the following:
Other side effects are:
Very common(may affect more than 1 in 10 people):
Fluid retention in the legs or feet, low potassium levels in the blood, elevated liver function tests, high blood pressure, urinary tract infection, diarrhea.
Common(may affect up to 1 in 10 people): High levels of fats in the blood, chest pain, irregular heartbeat (atrial fibrillation), heart failure, rapid heartbeat, severe infections (sepsis), bone fractures, indigestion, blood in the urine, skin rash.
Uncommon(may affect up to 1 in 100 people): Adrenal gland problems (related to salt and water problems), abnormal heart rhythm (arrhythmia), muscle weakness and/or muscle pain.
Rare(may affect up to 1 in 1,000 people): Lung irritation (also called allergic alveolitis), liver failure (also called acute hepatic insufficiency)
Frequency not known(frequency cannot be estimated from the available data): Heart attack, changes in the electrocardiogram (ECG) (QT prolongation), severe allergic reactions with difficulty swallowing or breathing, face, lips, tongue, or throat swelling, or itchy rash.
Bone density loss may occur in men receiving treatment for prostate cancer. This medicine in combination with prednisone or prednisolone may increase this bone density loss.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines and Healthcare Products Agency (AEMPS) at www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the label of the HDPE bottle after EXP. The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Abiraterona Farmoz
Appearance and packaging of the product
Abiraterona Farmoz 250 mg tablets are white or almost white, oval-shaped tablets.
The tablets are packed in a child-resistant plastic bottle. Each pack contains a bottle of 120 tablets.
Marketing authorisation holder and manufacturer
Farmoz - Sociedade Técnico-Medicinal, S.A.
Rua da Tapada Grande, nº 2, Abrunheira
2710-089 Sintra
Portugal
Manufacturer
Tecnimede - Sociedade Técnico Medicinal, S.A.
Quinta da Cerca, Caixaria
2565-187 Dois Portos
Portugal
Date of last revision of this leaflet:February 2024
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) www.aemps.gob.es/